[Featured Stock] Three Billion Rises 13% on News of Collaboration with Global Genomics Company Somagen

Three Billion is showing strength following news of its collaboration with global genomics company SomaGen.

According to the Korea Exchange on the 20th, as of 10:48 AM, Three Billion is trading at 3,680 KRW, up 13.93% (450 KRW) from the previous trading day. The news of collaboration with global genomics company SomaGen appears to have driven the stock price higher.

Three Billion announced that it signed a memorandum of understanding (MOU) with SomaGen to provide genetic testing for rare disease diagnosis. SomaGen receives specimens from suspected rare disease patients referred by medical and research institutions in the United States and produces genetic mutation data of the patients.

Through this agreement, Three Billion plans to utilize SomaGen’s network of local medical professionals in the U.S. and its genomic data production capabilities. Additionally, both companies will actively supply rapid diagnostic testing services. They plan to strengthen cooperative activities such as joint marketing of genetic tests for rare disease diagnosis targeting rare disease patients in the United States.